オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/08 | 2,099 | 2,100 | 2,003 | 2,047 | +61 | +3.1% | 1,396,300 |
2020/06/05 | 2,018 | 2,160 | 1,967 | 1,986 | -100 | -4.8% | 4,637,900 |
2020/06/04 | 1,992 | 2,086 | 1,941 | 2,086 | +400 | +23.7% | 5,838,600 |
2020/06/03 | 1,700 | 1,702 | 1,633 | 1,686 | -4 | -0.2% | 440,700 |
2020/06/02 | 1,675 | 1,744 | 1,657 | 1,690 | +30 | +1.8% | 710,700 |
2020/06/01 | 1,650 | 1,673 | 1,611 | 1,660 | +12 | +0.7% | 400,600 |
2020/05/29 | 1,650 | 1,681 | 1,626 | 1,648 | -2 | -0.1% | 441,600 |
2020/05/28 | 1,700 | 1,721 | 1,604 | 1,650 | -90 | -5.2% | 1,336,900 |
2020/05/27 | 1,647 | 1,889 | 1,630 | 1,740 | +173 | +11% | 6,046,500 |
2020/05/26 | 1,611 | 1,612 | 1,542 | 1,567 | -47 | -2.9% | 464,400 |
2020/05/25 | 1,662 | 1,673 | 1,606 | 1,614 | -36 | -2.2% | 391,800 |
2020/05/22 | 1,591 | 1,650 | 1,586 | 1,650 | +50 | +3.1% | 513,600 |
2020/05/21 | 1,659 | 1,737 | 1,600 | 1,600 | +10 | +0.6% | 1,243,700 |
2020/05/20 | 1,566 | 1,599 | 1,520 | 1,590 | +40 | +2.6% | 685,200 |
2020/05/19 | 1,490 | 1,594 | 1,451 | 1,550 | +87 | +5.9% | 742,500 |
2020/05/18 | 1,415 | 1,469 | 1,397 | 1,463 | +63 | +4.5% | 278,700 |
2020/05/15 | 1,420 | 1,430 | 1,360 | 1,400 | -4 | -0.3% | 269,600 |
2020/05/14 | 1,433 | 1,476 | 1,392 | 1,404 | -24 | -1.7% | 323,800 |
2020/05/13 | 1,408 | 1,448 | 1,394 | 1,428 | +20 | +1.4% | 305,800 |
2020/05/12 | 1,380 | 1,533 | 1,370 | 1,408 | +38 | +2.8% | 850,900 |
2020/05/11 | 1,381 | 1,400 | 1,330 | 1,370 | -38 | -2.7% | 353,400 |
2020/05/08 | 1,451 | 1,452 | 1,376 | 1,408 | -17 | -1.2% | 372,900 |
2020/05/07 | 1,351 | 1,447 | 1,351 | 1,425 | +47 | +3.4% | 391,500 |
2020/05/01 | 1,341 | 1,388 | 1,312 | 1,378 | +23 | +1.7% | 287,900 |
2020/04/30 | 1,383 | 1,406 | 1,352 | 1,355 | -12 | -0.9% | 354,600 |
2020/04/28 | 1,317 | 1,378 | 1,314 | 1,367 | +42 | +3.2% | 230,100 |
2020/04/27 | 1,299 | 1,339 | 1,278 | 1,325 | +40 | +3.1% | 215,400 |
2020/04/24 | 1,330 | 1,330 | 1,279 | 1,285 | -29 | -2.2% | 248,400 |
2020/04/23 | 1,288 | 1,317 | 1,273 | 1,314 | +47 | +3.7% | 240,400 |
2020/04/22 | 1,340 | 1,340 | 1,264 | 1,267 | -81 | -6% | 355,200 |
2020/04/21 | 1,387 | 1,420 | 1,327 | 1,348 | -9 | -0.7% | 366,300 |
2020/04/20 | 1,332 | 1,376 | 1,332 | 1,357 | +12 | +0.9% | 156,900 |
2020/04/17 | 1,357 | 1,370 | 1,326 | 1,345 | -12 | -0.9% | 221,300 |
2020/04/16 | 1,361 | 1,369 | 1,327 | 1,357 | -13 | -0.9% | 157,100 |
2020/04/15 | 1,371 | 1,401 | 1,357 | 1,370 | -15 | -1.1% | 221,900 |
2020/04/14 | 1,344 | 1,415 | 1,336 | 1,385 | +65 | +4.9% | 426,600 |
2020/04/13 | 1,310 | 1,361 | 1,290 | 1,320 | -3 | -0.2% | 238,400 |
2020/04/10 | 1,350 | 1,374 | 1,295 | 1,323 | -34 | -2.5% | 248,900 |
2020/04/09 | 1,271 | 1,374 | 1,261 | 1,357 | +91 | +7.2% | 420,500 |
2020/04/08 | 1,256 | 1,278 | 1,219 | 1,266 | +9 | +0.7% | 205,500 |
2020/04/07 | 1,250 | 1,299 | 1,216 | 1,257 | +42 | +3.5% | 336,500 |
2020/04/06 | 1,168 | 1,237 | 1,160 | 1,215 | +38 | +3.2% | 341,800 |
2020/04/03 | 1,280 | 1,286 | 1,159 | 1,177 | -73 | -5.8% | 441,600 |
2020/04/02 | 1,231 | 1,285 | 1,224 | 1,250 | +8 | +0.6% | 270,900 |
2020/04/01 | 1,300 | 1,313 | 1,231 | 1,242 | -70 | -5.3% | 337,200 |
2020/03/31 | 1,370 | 1,386 | 1,307 | 1,312 | +17 | +1.3% | 376,900 |
2020/03/30 | 1,260 | 1,329 | 1,258 | 1,295 | -9 | -0.7% | 320,800 |
2020/03/27 | 1,375 | 1,394 | 1,286 | 1,304 | -56 | -4.1% | 599,100 |
2020/03/26 | 1,429 | 1,462 | 1,324 | 1,360 | -77 | -5.4% | 502,200 |
2020/03/25 | 1,448 | 1,505 | 1,409 | 1,437 | +19 | +1.3% | 702,900 |
1201~
1250
件表示中 / 2785件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 57,400円 | +3771.0% | - | 0.00% | - | 5.20倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステムリム | 31,700円 | - | - | 0.00% | - | 2.92倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
Chordia | 23,000円 | - | - | 0.00% | - | 4.89倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
大幸薬品 | 27,300円 | +0.1% | -70.9% | 0.00% | 45.65倍 | 1.72倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
レナサイエンス | 101,700円 | -34.5% | - | 0.00% | 280.94倍 | 8.43倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
市場注目の銘柄
チャート関連のコラム